Vaccine Skepticism Should Not Be Ignored in US Outbound Travel Recovery, Says GlobalData

GlobalData | April 30, 2021

Vaccine skepticism coupled with COVID-19 concerns will continue to affect US outbound travel recovery in 2021 and potentially 2022, says GlobalData, a leading data and analytics company. COVID-19 concerns are high in the US. According to GlobalData’s Q1 2021 consumer survey, 52% of US respondents stated they were ‘extremely concerned’ about the impact of the COVID-19 pandemic in general, which is 10% higher than the global average. However, GlobalData’s Live Verdict Poll found that 23% of respondents in North America did not intend to take a vaccine against COVID-19. This was higher than any other region and suggests that a large p...